Nakshatri, H
Appaiah, H N
Anjanappa, M
Gilley, D
Tanaka, H
Badve, S
Crooks, P A
Mathews, W
Sweeney, C
Bhat-Nakshatri, P
Article History
Received: 30 May 2014
Revised: 3 December 2014
Accepted: 5 December 2014
First Online: 22 January 2015
Competing interests
: HN, PAC, WM, and CS are the co-founders of Leuchemix Inc., which is developing parthenolide and its analogs as anti-cancer agents. The other authors declare no conflict of interest.